Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII
Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained uncle...
Saved in:
Published in | Haematologica (Roma) Vol. 101; no. 4; pp. 427 - 436 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Ferrata Storti Foundation
01.04.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 1592-8721 0390-6078 1592-8721 |
DOI | 10.3324/haematol.2015.131441 |
Cover
Abstract | Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3. |
---|---|
AbstractList | Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3.Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3. Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3. Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α IIb β 3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α IIb β 3 . Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α IIb β 3 . Vice versa , star-like fibrin formation from platelets of a patient with deficiency in α IIb β 3 (Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α IIb β 3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α IIb β 3 . Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin αIIbβ3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin αIIbβ3. Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin αIIbβ3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in αIIbβ3 (Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial αIIbβ3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin αIIbβ3. |
Author | Mattheij, Nadine J A Cosemans, Judith M E M Suylen, Dennis P L Swieringa, Frauke McCarty, Owen J T May, Frauke Nolte, Marc W Mastenbroek, Tom G Berny-Lang, Michelle A Heemskerk, Johan W M Baaten, Constance C F M J van der Meijden, Paola E J Henskens, Yvonne M C Hackeng, Tilman M Beckers, Erik A M |
AuthorAffiliation | 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands 4 Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands 3 CSL Behring GmbH, Marburg, Germany 2 Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA 5 Department of Internal Medicine, Maastricht University Medical Center, The Netherlands |
AuthorAffiliation_xml | – name: 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – name: 5 Department of Internal Medicine, Maastricht University Medical Center, The Netherlands – name: 4 Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands – name: 3 CSL Behring GmbH, Marburg, Germany – name: 2 Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA |
Author_xml | – sequence: 1 givenname: Nadine J A surname: Mattheij fullname: Mattheij, Nadine J A organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 2 givenname: Frauke surname: Swieringa fullname: Swieringa, Frauke organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 3 givenname: Tom G surname: Mastenbroek fullname: Mastenbroek, Tom G organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 4 givenname: Michelle A surname: Berny-Lang fullname: Berny-Lang, Michelle A organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA – sequence: 5 givenname: Frauke surname: May fullname: May, Frauke organization: CSL Behring GmbH, Marburg, Germany – sequence: 6 givenname: Constance C F M J surname: Baaten fullname: Baaten, Constance C F M J organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 7 givenname: Paola E J surname: van der Meijden fullname: van der Meijden, Paola E J organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 8 givenname: Yvonne M C surname: Henskens fullname: Henskens, Yvonne M C organization: Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands – sequence: 9 givenname: Erik A M surname: Beckers fullname: Beckers, Erik A M organization: Department of Internal Medicine, Maastricht University Medical Center, The Netherlands – sequence: 10 givenname: Dennis P L surname: Suylen fullname: Suylen, Dennis P L organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 11 givenname: Marc W surname: Nolte fullname: Nolte, Marc W organization: CSL Behring GmbH, Marburg, Germany – sequence: 12 givenname: Tilman M surname: Hackeng fullname: Hackeng, Tilman M organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 13 givenname: Owen J T surname: McCarty fullname: McCarty, Owen J T organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA – sequence: 14 givenname: Johan W M surname: Heemskerk fullname: Heemskerk, Johan W M organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands – sequence: 15 givenname: Judith M E M surname: Cosemans fullname: Cosemans, Judith M E M email: judith.cosemans@maastrichtuniversity.nl organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands judith.cosemans@maastrichtuniversity.nl |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26721892$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkctqFUEQhhuJmIu-gcgs3cyxrzPTG0EORgcCbhTcDdW3kw493ceengQfSx8kz5Q-JoZkVcVfP99PVZ2io5iiRegtwRvGKP9wCXaGksKGYiI2hBHOyQt0QoSk7dBTcvSkP0any3KFMcVS9q_QMe2qOEh6gm62CYo1zT7UEmxZGrdGXXyKjY-Pamvs3kZjY2mcV7lOXMo1_WC79lCtxe4O8u2fcVS3f1kD0TQlQ1x2YS0w-wiLbRzoknLzcxzH1-ilg7DYNw_1DP04__x9-7W9-PZl3H66aE1dsrSql9yBxIbqoddakV4ZpaSRjGgrGSNGd1RqLhQBQZ2FToAA4zhgoNwpdobGe65JcDXts58h_54S-OmfkPJugly8DnYCdrgJF0b0HVfYDKC4YtZSNTDqsKysj_es_apma3Q9R4bwDPp8Ev3ltEvXk8CYM0kq4P0DIKdfq13KNPtF2xAg2rQuE-n7Xg60Y6Ja3z3Negz5_zl2B0mepAs |
ContentType | Journal Article |
Copyright | Copyright© Ferrata Storti Foundation. Copyright© Ferrata Storti Foundation 2016 |
Copyright_xml | – notice: Copyright© Ferrata Storti Foundation. – notice: Copyright© Ferrata Storti Foundation 2016 |
DBID | CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3324/haematol.2015.131441 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1592-8721 |
EndPage | 436 |
ExternalDocumentID | oai_doaj_org_article_a3218945d5764b0d8ab4b3ee2b832f09 PMC5004391 26721892 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01HL101972 – fundername: NHLBI NIH HHS grantid: R01 HL101972 |
GroupedDBID | --- 29I 2WC 53G 5GY 5RE 5VS AAFWJ ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW C1A CGR CS3 CUY CVF DIK E3Z EBS ECM EIF EJD F5P FRP GROUPED_DOAJ H13 HYE KQ8 M~E NPM OK1 P2P RHF RHI RNS RPM SJN SV3 TFS TR2 UDS W8F WOQ WOW 7X8 AFPKN OVT 5PM |
ID | FETCH-LOGICAL-d332t-b794fa90d2c87ccb17bdbb9d931ce9331dc629c45b1a52fea65a5adf4a0a24fb3 |
IEDL.DBID | DOA |
ISSN | 1592-8721 0390-6078 |
IngestDate | Wed Aug 27 01:30:36 EDT 2025 Thu Aug 21 18:08:21 EDT 2025 Thu Jul 10 22:57:06 EDT 2025 Thu Jan 02 22:22:18 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | Copyright© Ferrata Storti Foundation. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-d332t-b794fa90d2c87ccb17bdbb9d931ce9331dc629c45b1a52fea65a5adf4a0a24fb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 FS and TGM contributed equally to this work |
OpenAccessLink | https://doaj.org/article/a3218945d5764b0d8ab4b3ee2b832f09 |
PMID | 26721892 |
PQID | 1777982635 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a3218945d5764b0d8ab4b3ee2b832f09 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5004391 proquest_miscellaneous_1777982635 pubmed_primary_26721892 |
PublicationCentury | 2000 |
PublicationDate | 2016-04-01 |
PublicationDateYYYYMMDD | 2016-04-01 |
PublicationDate_xml | – month: 04 year: 2016 text: 2016-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy |
PublicationTitle | Haematologica (Roma) |
PublicationTitleAlternate | Haematologica |
PublicationYear | 2016 |
Publisher | Ferrata Storti Foundation |
Publisher_xml | – name: Ferrata Storti Foundation |
References | 11805836 - Nature. 2002 Jan 10;415(6868):175-9 25027852 - Nat Commun. 2014 Jul 16;5:4257 12529747 - Thromb Haemost. 2002 Dec;88(6):967-74 25331118 - Blood. 2014 Dec 18;124(26):3982-90 19967145 - Thromb Haemost. 2009 Dec;102(6):1149-56 26149024 - J Thromb Haemost. 2015 Jun;13 Suppl 1:S2-9 24336148 - J Head Trauma Rehabil. 2014 Nov-Dec;29(6):522-6 16105983 - Blood. 2005 Dec 15;106(13):4146-51 22502645 - Platelets. 2012;23(3):229-42 23149559 - J Cereb Blood Flow Metab. 2013 Feb;33(2):287-92 23519467 - J Biol Chem. 2013 May 10;288(19):13325-36 15341700 - Curr Hematol Rep. 2004 Sep;3(5):338-43 15010476 - J Biol Chem. 2004 May 7;279(19):19854-9 16241952 - J Thromb Haemost. 2005 Nov;3(11):2545-53 12351391 - Blood. 2002 Oct 15;100(8):2827-31 11816711 - Thromb Haemost. 2001 Nov;86(5):1221-8 25184360 - Stroke. 2014 Oct;45(10):2995-3001 12853707 - Pathophysiol Haemost Thromb. 2003;33(1):4-15 11313254 - Blood. 2001 May 1;97(9):2648-56 25205226 - Mol Cell Proteomics. 2014 Dec;13(12):3435-45 2866189 - J Biol Chem. 1985 Dec 15;260(29):16012-20 20519511 - J Biol Chem. 2010 Jul 30;285(31):23629-38 16194197 - J Thromb Haemost. 2005 Oct;3(10):2185-92 23667186 - Cardiovasc Res. 2013 Jul 15;99(2):342-52 15131115 - J Biol Chem. 2004 Jul 16;279(29):30697-706 24338009 - J Biol Chem. 2014 Jan 24;289(4):2371-83 17082321 - Blood. 2007 Mar 1;109 (5):1931-7 22669259 - Cell Mol Life Sci. 2012 Oct;69(20):3481-92 16840732 - Blood. 2006 Nov 1;108(9):3045-52 21037087 - Blood. 2011 Jan 13;117(2):651-60 20479008 - J Biol Chem. 2010 Jul 23;285(30):23410-9 22869793 - Blood. 2012 Oct 11;120(15):e73-82 24443567 - J Biol Chem. 2014 Mar 7;289(10):6526-34 23303912 - Physiol Rev. 2013 Jan;93(1):327-58 23995838 - J Biol Chem. 2013 Oct 11;288(41):29621-32 23106920 - J Thromb Haemost. 2013 Jan;11(1):2-16 18757293 - Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2023-9 19679287 - JACC Cardiovasc Imaging. 2009 Aug;2(8):987-96 |
References_xml | – reference: 23149559 - J Cereb Blood Flow Metab. 2013 Feb;33(2):287-92 – reference: 12529747 - Thromb Haemost. 2002 Dec;88(6):967-74 – reference: 16241952 - J Thromb Haemost. 2005 Nov;3(11):2545-53 – reference: 20519511 - J Biol Chem. 2010 Jul 30;285(31):23629-38 – reference: 21037087 - Blood. 2011 Jan 13;117(2):651-60 – reference: 23995838 - J Biol Chem. 2013 Oct 11;288(41):29621-32 – reference: 24336148 - J Head Trauma Rehabil. 2014 Nov-Dec;29(6):522-6 – reference: 22869793 - Blood. 2012 Oct 11;120(15):e73-82 – reference: 25331118 - Blood. 2014 Dec 18;124(26):3982-90 – reference: 2866189 - J Biol Chem. 1985 Dec 15;260(29):16012-20 – reference: 15010476 - J Biol Chem. 2004 May 7;279(19):19854-9 – reference: 11816711 - Thromb Haemost. 2001 Nov;86(5):1221-8 – reference: 15131115 - J Biol Chem. 2004 Jul 16;279(29):30697-706 – reference: 25027852 - Nat Commun. 2014 Jul 16;5:4257 – reference: 23303912 - Physiol Rev. 2013 Jan;93(1):327-58 – reference: 12853707 - Pathophysiol Haemost Thromb. 2003;33(1):4-15 – reference: 23519467 - J Biol Chem. 2013 May 10;288(19):13325-36 – reference: 12351391 - Blood. 2002 Oct 15;100(8):2827-31 – reference: 16840732 - Blood. 2006 Nov 1;108(9):3045-52 – reference: 23667186 - Cardiovasc Res. 2013 Jul 15;99(2):342-52 – reference: 19679287 - JACC Cardiovasc Imaging. 2009 Aug;2(8):987-96 – reference: 22502645 - Platelets. 2012;23(3):229-42 – reference: 19967145 - Thromb Haemost. 2009 Dec;102(6):1149-56 – reference: 23106920 - J Thromb Haemost. 2013 Jan;11(1):2-16 – reference: 18757293 - Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2023-9 – reference: 16194197 - J Thromb Haemost. 2005 Oct;3(10):2185-92 – reference: 25184360 - Stroke. 2014 Oct;45(10):2995-3001 – reference: 20479008 - J Biol Chem. 2010 Jul 23;285(30):23410-9 – reference: 26149024 - J Thromb Haemost. 2015 Jun;13 Suppl 1:S2-9 – reference: 25205226 - Mol Cell Proteomics. 2014 Dec;13(12):3435-45 – reference: 16105983 - Blood. 2005 Dec 15;106(13):4146-51 – reference: 11805836 - Nature. 2002 Jan 10;415(6868):175-9 – reference: 15341700 - Curr Hematol Rep. 2004 Sep;3(5):338-43 – reference: 22669259 - Cell Mol Life Sci. 2012 Oct;69(20):3481-92 – reference: 24443567 - J Biol Chem. 2014 Mar 7;289(10):6526-34 – reference: 17082321 - Blood. 2007 Mar 1;109 (5):1931-7 – reference: 11313254 - Blood. 2001 May 1;97(9):2648-56 – reference: 24338009 - J Biol Chem. 2014 Jan 24;289(4):2371-83 |
SSID | ssj0020997 |
Score | 2.4077702 |
Snippet | Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular... |
SourceID | doaj pubmedcentral proquest pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 427 |
SubjectTerms | Animals Blood Coagulation Blood Platelets - drug effects Blood Platelets - metabolism Blood Platelets - pathology Crotalid Venoms - pharmacology Factor Va - chemistry Factor Va - metabolism Factor Xa - chemistry Factor Xa - metabolism Factor XIII - chemistry Factor XIII - metabolism Fibrin - chemistry Fibrin - metabolism Fibrinogen - chemistry Fibrinogen - metabolism Humans Lectins, C-Type Mice Mice, Knockout Molecular Probes - chemistry Phosphatidylserines - chemistry Phosphatidylserines - metabolism Platelet Activation - drug effects Platelet Glycoprotein GPIIb-IIIa Complex - chemistry Platelet Glycoprotein GPIIb-IIIa Complex - metabolism Primary Cell Culture Protein Binding Thrombasthenia - blood Thrombasthenia - pathology Thrombin - pharmacology |
Title | Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26721892 https://www.proquest.com/docview/1777982635 https://pubmed.ncbi.nlm.nih.gov/PMC5004391 https://doaj.org/article/a3218945d5764b0d8ab4b3ee2b832f09 |
Volume | 101 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kB_EimvhYH6EF8TZm-jU9fUxCQkaIJwN7G_ppFrQ3uBPFn6U_JL8pVdOzS1YEL54GemC66K-aqpqq-oqQt4Y3ykvHsHoKAhQWVNVK5isd0aAHr5txdML5x-bsQn6Yq_mdUV9YE1bogcvBHVgBRshIFcAxlq4OrXXSiRi5A11MpXWvNvU6mJpCLewHHfMHBoIjsIKlaU6A93BwaZEMdYlpB6beM4ERxUTY_zcv889iyTvW5_QReTi5jfSwiPuY3It5l-wdZtji60_6jo6FnOMf8l1y_3zKl--RH8dL8CUDvfoCD0BoRdGOIRZ0kTer1XoS7kATdgBkumlppN8XlhZKCVi--dV17ua3oDYHOqCV-wyKa7GaZhVpGd1D513XPSEXpyefjs-qadRCFeBQhsrBtUzW1IH7VnvvmHbBOROMYD4aIVjwDTdeKses4inaRlllQ5K2tlwmJ56SnbzM8TmhzqWgkBXMRy8lt1bzZHRsnfNKqcRn5AjPur8qbBo98luPC4B6P6He_wv1GXmzRqqH-4BJDpvj8nrVM621aZFiZ0aeFeQ2W_FG42dBBL2F6ZYs22_y4nLk3FaYMjXsxf8Q_iV5ALrXlPqfV2Rn-HYdX4NrM7j9UYtvAXkG-ts |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coated+platelets+function+in+platelet-dependent+fibrin+formation+via+integrin+%CE%B1IIb%CE%B23+and+transglutaminase+factor+XIII&rft.jtitle=Haematologica+%28Roma%29&rft.au=Mattheij%2C+Nadine+J+A&rft.au=Swieringa%2C+Frauke&rft.au=Mastenbroek%2C+Tom+G&rft.au=Berny-Lang%2C+Michelle+A&rft.date=2016-04-01&rft.eissn=1592-8721&rft.volume=101&rft.issue=4&rft.spage=427&rft_id=info:doi/10.3324%2Fhaematol.2015.131441&rft_id=info%3Apmid%2F26721892&rft.externalDocID=26721892 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1592-8721&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1592-8721&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1592-8721&client=summon |